Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: A systematic scoping review and narrative synthesis-Reference-Cited by-同舟云学术

Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: A systematic scoping review and narrative synthesis

Published:2023-10 Issue:10 Volume:29 Page:1280-1288
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Reynolds Gemma,Sim Beatrice,Anderson Mary Ann,Spelman Tim,Teh Benjamin W.,Slavin Monica A.,Thursky Karin A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference48 articles.

1. Penn medicine and children's hospital of philadelphia announce partnership with Costa Rica for CAR T cell therapy,2022

2. Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: systematic review and meta-analysis;Telli Dizman;Expert Rev Anti Infect Ther,2022

3. Post-marketing surveillance of CAR-T-cell therapies: analysis of the FDA Adverse event reporting system (FAERS) database;Fusaroli;Drug Saf,2022

4. Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma;Locke;N Engl J Med,2022

5. Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma;Bishop;N Engl J Med,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies;Journal of Translational Medicine;2024-07-02

2. Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies;Transplantation and Cellular Therapy;2024-07

3. Managing Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy;Clinical Hematology International;2024-04-29

4. Toxicités hématologiques après CAR-T cells, recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC);Bulletin du Cancer;2024-04

5. The Burden of Invasive Fungal Disease Following Chimeric Antigen Receptor T-Cell Therapy and Strategies for Prevention;Open Forum Infectious Diseases;2024-03-13